Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy S Tracy

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 8, 2006
Identification of binding sites of non-I-helix water molecules in mammalian cytochromes p450Charles W Locuson, Timothy S Tracy
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 30, 2011
Development of an in vitro system with human liver microsomes for phenotyping of CYP2C9 genetic polymorphisms with a mechanism-based inactivatorDarcy R Flora, Timothy S Tracy
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 30, 2010
Bilirubin glucuronidation revisited: proper assay conditions to estimate enzyme kinetics with recombinant UGT1A1Jin Zhou, Timothy S Tracy, Rory P Remmel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 30, 2010
Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates/inhibitorsJin Zhou, Timothy S Tracy, Rory P Remmel
Molecular Pharmacology|August 10, 2007
Polymorphic variants of CYP2C9: mechanisms involved in reduced catalytic activityLian Wei, Charles W Locuson, Timothy S Tracy
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2009
Glucuronidation of dihydrotestosterone and trans-androsterone by recombinant UDP-glucuronosyltransferase (UGT) 1A4: evidence for multiple UGT1A4 aglycone binding sitesJin Zhou, Timothy S Tracy, Rory P Remmel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 12, 2011
The deaminated metabolite of gemcitabine, 2',2'-difluorodeoxyuridine, modulates the rate of gemcitabine transport and intracellular phosphorylation via deoxycytidine kinaseLucy S Hodge, Mitchell E Taub, Timothy S Tracy
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 26, 2007
Visible spectra of type II cytochrome P450-drug complexes: evidence that "incomplete" heme coordination is commonCharles W Locuson, J Matthew Hutzler, Timothy S Tracy
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 11, 2010
CYP2C9-CYP3A4 protein-protein interactions: role of the hydrophobic N terminusMurali Subramanian, Harrison Tam, Helen Zheng, et al.
Archives of Biochemistry and Biophysics|March 21, 2006
Heteroactivator effects on the coupling and spin state equilibrium of CYP2C9Charles W Locuson, Peter M Gannett, Timothy S Tracy
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 8, 2006
Identification of binding sites of non-I-helix water molecules in mammalian cytochromes p450Charles W Locuson, Timothy S Tracy
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 30, 2011
Development of an in vitro system with human liver microsomes for phenotyping of CYP2C9 genetic polymorphisms with a mechanism-based inactivatorDarcy R Flora, Timothy S Tracy
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 30, 2010
Bilirubin glucuronidation revisited: proper assay conditions to estimate enzyme kinetics with recombinant UGT1A1Jin Zhou, Timothy S Tracy, Rory P Remmel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 30, 2010
Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates/inhibitorsJin Zhou, Timothy S Tracy, Rory P Remmel
Molecular Pharmacology|August 10, 2007
Polymorphic variants of CYP2C9: mechanisms involved in reduced catalytic activityLian Wei, Charles W Locuson, Timothy S Tracy
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 17, 2009
Glucuronidation of dihydrotestosterone and trans-androsterone by recombinant UDP-glucuronosyltransferase (UGT) 1A4: evidence for multiple UGT1A4 aglycone binding sitesJin Zhou, Timothy S Tracy, Rory P Remmel
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 12, 2011
The deaminated metabolite of gemcitabine, 2',2'-difluorodeoxyuridine, modulates the rate of gemcitabine transport and intracellular phosphorylation via deoxycytidine kinaseLucy S Hodge, Mitchell E Taub, Timothy S Tracy
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 26, 2007
Visible spectra of type II cytochrome P450-drug complexes: evidence that "incomplete" heme coordination is commonCharles W Locuson, J Matthew Hutzler, Timothy S Tracy
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 11, 2010
CYP2C9-CYP3A4 protein-protein interactions: role of the hydrophobic N terminusMurali Subramanian, Harrison Tam, Helen Zheng, et al.
Archives of Biochemistry and Biophysics|March 21, 2006
Heteroactivator effects on the coupling and spin state equilibrium of CYP2C9Charles W Locuson, Peter M Gannett, Timothy S Tracy
Pageof 8